GLP-1 Drugs Are Quietly Rewriting America's Food Culture, And Big Food Is Scrambling to Keep Up
GLP-1 Drugs Are Quietly Rewriting America's Food Culture, And Big Food Is Scrambling to Keep Up The Quiet Revolution at the Dinner Table Something strange is happening at American dinner tables. Grocery carts are getting lighter. Fast-food drive-throughs are seeing fewer cars after 6 p.m. And somewhere in the boardrooms of the world's biggest food companies, executives are staring at sales charts that look... wrong. No food safety scandal. No economic crash. No viral TikTok diet trend wiping out chip sales overnight. Just a small injection. Once a week. GLP-1 drugs , the class of medications that includes household names like Ozempic , Wegovy , and Mounjaro , have become one of the most disruptive forces the food industry has ever encountered. And unlike fad diets or wellness crazes that fade in a season, this one has biology on its side. Approximately one in eight American adults is currently taking drugs from the class of GLP-1 agonists now popular for weight loss, ...